Status:
COMPLETED
Prediction of Risk Factors for Adverse Events After Head and Neck Vascular Recanalization Surgery Based on Machine Learning Models
Lead Sponsor:
Tang-Du Hospital
Conditions:
Machine Learning
Eligibility:
All Genders
18-90 years
Brief Summary
Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models
Eligibility Criteria
Inclusion
- All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
- Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
- Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
- Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
- Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
- Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk events after head and neck revascularization are 50% to 69%;
- Sign the project informed consent form
Exclusion
- Patients with poor overall condition and intolerance to general anesthesia;
- Patients with mental illness or severe mental illness;
- Severe respiratory system diseases;
- Pregnant and lactating women;
- Participating in another clinical study;
- Patients with advanced tumors or those who are expected to die within one year;
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2023
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT06120478
Start Date
January 1 2019
End Date
October 1 2023
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038